{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:05:19Z","timestamp":1791266719666,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T00:00:00Z","timestamp":1355443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00210-012-0821-4","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T23:23:33Z","timestamp":1360970613000},"page":"247-253","source":"Crossref","is-referenced-by-count":44,"title":["In vitro and in vivo pharmacological profile of the selective \u03b23-adrenoceptor agonist mirabegron in rats"],"prefix":"10.1007","volume":"386","author":[{"given":"Toshiki","family":"Hatanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Someya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ueshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Sasamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,14]]},"reference":[{"key":"821_CR1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Kerrebroeck PV, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167\u2013178","journal-title":"Neurourol Urodyn"},{"key":"821_CR2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/physrev.00038.2003","volume":"84","author":"K-E Andersson","year":"2004","unstructured":"Andersson K-E, Arner A (2004) Urinary bladder contraction and relaxation physiology and pathophysiology. Physiol Rev 84:935\u2013986","journal-title":"Physiol Rev"},{"key":"821_CR3","doi-asserted-by":"crossref","unstructured":"Athanasopoulos A, Giannitsas K (2011) An overview of the clinical use of antimuscarinics in the treatment of overactive bladder. Adv Urol 816342","DOI":"10.1155\/2011\/820816"},{"key":"821_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1569-9056(10)60758-0","volume":"9","author":"C Chapple","year":"2010","unstructured":"Chapple C, Wyndaele JJ, Van Kerrebroeck P, Radziszewski P, Dvorak V, Boerrigter P (2010) Dose-ranging study of once-daily mirabegron (YM-178) a novel selective \u03b23-adrenoceptor agonist in patients with overactive bladder (OAB). Eur Urol Suppl 9:249","journal-title":"Eur Urol Suppl"},{"key":"821_CR5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1146\/annurev.pharmtox.41.1.691","volume":"41","author":"WC Groat de","year":"2001","unstructured":"de Groat WC, Yoshimura N (2001) Pharmacology of the lower urinary tract. Annu Rev Pharmacol Toxicol 41:691\u2013721","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"821_CR6","first-page":"1000","volume":"269","author":"JA Dolan","year":"1994","unstructured":"Dolan JA, Muenkel HA, Burns MG, Pellegrino SM, Fraser CM, Pietri F, Strosberg AD, Largis EE, Dutia MD, Bloom JD (1994) \u03b23 Adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. J Pharmacol Exp Ther 269:1000\u20131006","journal-title":"J Pharmacol Exp Ther"},{"key":"821_CR7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-5347(01)61994-3","volume":"161","author":"T Fujimura","year":"1999","unstructured":"Fujimura T, Tamura K, Tsutsumi T, Yamamoto T, Nakamura K, Koibuchi Y, Kobayayashi M, Yamaguchi O (1999) Expression and possible functional role of the \u03b23-adrenoceptor in human and rat detrusor muscle. J Urol 161:680\u2013685","journal-title":"J Urol"},{"key":"821_CR8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/ageing\/23.3.246","volume":"23","author":"DJ Griffiths","year":"1994","unstructured":"Griffiths DJ, McCracken PN, Harrison GM, Gormley EA, Moore K, Hooper R, McEwan AJB, Triscott J (1994) Cerebral aetiology of urinary urge incontinence in elderly people. Age Ageing 23:246\u2013250","journal-title":"Age Ageing"},{"key":"821_CR9","first-page":"40","volume":"5","author":"SS Hegde","year":"2004","unstructured":"Hegde SS, Mammen M, Jasper JR (2004) Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies. Curr Opin Investig Drugs 5:40\u201344","journal-title":"Curr Opin Investig Drugs"},{"key":"821_CR10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjp.0702358","volume":"126","author":"Y Igawa","year":"1999","unstructured":"Igawa Y, Yamazaki Y, Takeda H, Hayakawa K, Akahane M, Ajisawa Y, Yoneyama T, Nishizawa O, Andersson K-E (1999) Functional and molecular biological evidence for a possible \u03b23-adrenoceptor in the human detrusor muscle. Br J Pharmacol 126:819\u2013825","journal-title":"Br J Pharmacol"},{"issue":"12","key":"821_CR11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4111\/kju.2010.51.12.811","volume":"51","author":"Y Igawa","year":"2010","unstructured":"Igawa Y, Aizawa N, Homma Y (2010) Beta3-adrenoceptor agonists: possible role in the treatment of overactive bladder. Korean J Urol 51(12):811\u2013818","journal-title":"Korean J Urol"},{"key":"821_CR12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.5980\/jpnjurol1989.87.1221","volume":"87","author":"Y Ishiura","year":"1996","unstructured":"Ishiura Y (1996) Experimental study of voiding dysfunction induced by cerebral infarction in rats. Jpn J Urol 87:1221\u20131230","journal-title":"Jpn J Urol"},{"key":"821_CR13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0022-5347(05)64634-4","volume":"168","author":"K Kaidoh","year":"2002","unstructured":"Kaidoh K, Igawa Y, Takeda H, Yamazaki Y, Akahane S, Miyata H, Ajisawa Y, Nishizawa O, Andersson K-E (2002) Effects of selective \u03b22 and \u03b23-adrenoceptor agonists on detrusor hyperreflexia in conscious cerebral infarcted rats. J Urol 168:1247\u20131252","journal-title":"J Urol"},{"key":"821_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0090-4295(90)80048-R","volume":"35","author":"Z Khan","year":"1990","unstructured":"Khan Z, Starer P, Yang WC, Bhola A (1990) Analysis of voiding disorders in patients with cerebrovascular accidents. Urology 35:265\u2013270","journal-title":"Urology"},{"key":"821_CR15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1569-9056(11)60870-1","volume":"10","author":"V Khullar","year":"2011","unstructured":"Khullar V, Cambronero J, Stroberg P, Angulo J, Boerrigter P, Blauwet MB, Wooning M (2011) The efficacy and tolerability of mirabegron in patients with overactive bladder\u2014results from a European-Australian Phase III trial. Eur Urol Suppl 10:278\u2013279","journal-title":"Eur Urol Suppl"},{"key":"821_CR16","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0090-4295(01)00986-4","volume":"57","author":"JN Liberman","year":"2001","unstructured":"Liberman JN, Hunt TL, Stewart WF, Wein A, Zhou Z, Herzog AR, Lipton RB, Diokno AC (2001) Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community based survey. Urology 57:1044\u20131050","journal-title":"Urology"},{"key":"821_CR17","first-page":"634","volume":"42","author":"SB Liggett","year":"1992","unstructured":"Liggett SB (1992) Functional properties of the rat and human \u03b23-adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells. Mol Pharmacol 42:634\u2013637","journal-title":"Mol Pharmacol"},{"key":"821_CR18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","volume":"20","author":"EZ Longa","year":"1989","unstructured":"Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84\u201391","journal-title":"Stroke"},{"key":"821_CR19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1464-410x.1999.00251.x","volume":"84","author":"H Madersbacher","year":"1999","unstructured":"Madersbacher H, Halaska M, Voigt R, H\u00f6fner K (1999) A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence. BJU Int 84:646\u2013651","journal-title":"BJU Int"},{"key":"821_CR20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00345-009-0416-y","volume":"27","author":"MC Michel","year":"2009","unstructured":"Michel MC, Sand C (2009) Effect of pre-contraction on \u03b2-adrenoceptor-mediated relaxation of rat urinary bladder. World J Urol 27:711\u2013715","journal-title":"World J Urol"},{"key":"821_CR21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2011.03.014","volume":"131","author":"MC Michel","year":"2011","unstructured":"Michel MC, Ochodnicky P, Homma Y, Igawa Y (2011) \u03b2-Adrenoceptor agonist effects in experimental models of bladder dysfunction. Pharmacol Ther 131:40\u201349","journal-title":"Pharmacol Ther"},{"key":"821_CR22","first-page":"921","volume":"293","author":"Y Nakada","year":"2000","unstructured":"Nakada Y, Yokoyama O, Komatsu K, Kodama K, Yotsuyanagi S, Niikura S, Nagasaka Y, Namiki M (2000) Effects of aniracetam on bladder overactivity in rats with cerebral infarction. J Pharmacol Exp Ther 293:921\u2013928","journal-title":"J Pharmacol Exp Ther"},{"key":"821_CR23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1569-9056(11)60869-5","volume":"10","author":"V Nitti","year":"2011","unstructured":"Nitti V, Herschorn S, Auerbach S, Ayers M, Lee M, Martin N (2011) The efficacy and safety of mirabegron in patients with overactive bladder syndrome\u2014results from a North-American Phase III trial. Eur Urol Suppl 10:278","journal-title":"Eur Urol Suppl"},{"key":"821_CR24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0302-2838(03)00353-1","volume":"44","author":"R Pehrson","year":"2003","unstructured":"Pehrson R, Stenman E, Andersson K-E (2003) Effects of tramadol on rat detrusor overactivity induced by experimental cerebral infarction. Eur Urol 44:495\u2013499","journal-title":"Eur Urol"},{"key":"821_CR25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2005.02.023","volume":"512","author":"M Suzuki","year":"2005","unstructured":"Suzuki M, Ohtake A, Yoshino T, Yuyama H, Hayashi A, Ukai M, Okutsu H, Noguchi Y, Sato S, Sasamata M (2005) Effect of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats. Eur J Pharmacol 512:61\u201366","journal-title":"Eur J Pharmacol"},{"key":"821_CR26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.106.115840","volume":"321","author":"T Takasu","year":"2007","unstructured":"Takasu T, Ukai M, Sato S, Matsui T, Nagase I, Maruyama T, Sasamata M, Miyata K, Uchida H, Yamaguchi O (2007) Effect of (R)-2-(2-Aminothiazol-4-yl)-4-{2-[(2-hydroxy-2- phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective \u03b23-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther 321:642\u2013647","journal-title":"J Pharmacol Exp Ther"},{"key":"821_CR27","first-page":"1367","volume":"288","author":"M Takeda","year":"1999","unstructured":"Takeda M, Obara K, Mizusawa T, Tomita Y, Arai K, Tsutsui T, Hatano A, Takahashi K, Nomura S (1999) Evidence for \u03b23-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods. J Pharmacol Exp Ther 288:1367\u20131373","journal-title":"J Pharmacol Exp Ther"},{"key":"821_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0090-4295(83)90099-7","volume":"21","author":"S Tsuchida","year":"1983","unstructured":"Tsuchida S, Noto H, Yamaguchi O, Itoh M (1983) Urodynamic studies on hemiplegic patients after cerebrovascular accident. Urology 21:315\u2013318","journal-title":"Urology"},{"key":"821_CR29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejphar.2005.06.029","volume":"518","author":"H Uchida","year":"2005","unstructured":"Uchida H, Shishido H, Nomiya M, Yamaguchi O (2005) Involvement of cyclic AMP-dependent and -independent mechanisms in the relaxation of rat detrusor muscle via \u03b2-adrenoceptors. Eur J Pharmacol 518:195\u2013202","journal-title":"Eur J Pharmacol"},{"key":"821_CR30","doi-asserted-by":"crossref","unstructured":"Wagg A, Compion G, Fahey A, Siddiqui E (2012) Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience. BJU Int. doi: 10.1111\/j.1464-410X.2012.11023.x","DOI":"10.1111\/j.1464-410X.2012.11023.x"},{"issue":"Suppl 5A","key":"821_CR31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0090-4295(01)01635-1","volume":"59","author":"O Yamaguchi","year":"2002","unstructured":"Yamaguchi O (2002) \u03b23-adrenoceptors in human detrusor muscle. Urology 59(Suppl 5A):25\u201329","journal-title":"Urology"},{"key":"821_CR32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.bjp.0701870","volume":"124","author":"Y Yamazaki","year":"1998","unstructured":"Yamazaki Y, Takeda H, Akahane M, Igawa Y, Nishizawa O, Ajisawa Y (1998) Species differences in the distribution of \u03b2-adrenoceptor subtypes in bladder smooth muscle. Br J Pharmacol 124:593\u2013599","journal-title":"Br J Pharmacol"},{"key":"821_CR33","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/ajpregu.1999.276.4.R935","volume":"276","author":"O Yokoyama","year":"1999","unstructured":"Yokoyama O, Yoshiyama M, Namik M, de Groat WC (1999) Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion. Am J Physiol Regul Integr Comp Physiol 276:935\u2013942","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"821_CR34","doi-asserted-by":"crossref","unstructured":"Yokoyama O, Yoshiyama M, Namiki M, de Groat MC (2002) Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats. Exp Neurol 173:129\u2013135","DOI":"10.1006\/exnr.2001.7833"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-012-0821-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-012-0821-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-012-0821-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T20:23:27Z","timestamp":1562703807000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-012-0821-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,14]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["821"],"URL":"https:\/\/doi.org\/10.1007\/s00210-012-0821-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,14]]}}}